News
Leading experts join the GMS Informatics Advisory Board
The national steering group of Genomic Medicine Sweden (GMS) has appointed Samuli Ripatti, Jayne Hehir-Kwa, Christian Gilissen, Augusto Rendon, Tony Håndstad and Mathias Ekman as members of the new GMS Informatics Advisory Board. “We are delighted to welcome this...
Genomic Medicine Sweden receives SEK 49.5 million for precision medicine investments
Today, the Swedish Ministry of Social Affairs announces that it is granting SEK 49.5 million to Genomic Medicine Sweden (GMS) to develop and intensify work in precision diagnostics, childhood cancer, rare diseases and data sharing. “This extensive investment...
Continued increase in the use of precision diagnostics in Swedish healthcare
A summary of the precision diagnostic analyses performed in routine healthcare in Sweden in 2023 shows that more than 90,800 clinical samples were analyzed. In addition to SARS-CoV-2, which continues to represent a significant proportion, many analyses were performed...
National study identifies hereditary causes of childhood cancer – for better follow-up and treatment
Follow-up and treatment of children with cancer is significantly improved when inherited genetic causes are also investigated, according to a new Swedish study. The results of the research study involving some 50 researchers and clinicians from across Sweden have been...
Paediatricians in Sweden propose whole genome sequencing as a routine diagnostic test for all childhood cancer patients
The Swedish Paediatric Association’s Section for Paediatric Haematology and Oncology recommends that whole genome sequencing should be a clinical routine at diagnosis for all childhood cancer patients. “For GMS Childhood Cancer, the statement is a...
Genomic Medicine Sweden awarded SEK 30 million for national and international data sharing for precision medicine
The Swedish Innovation Agency Vinnova has decided to fund the further development and implementation of the National Genomics Platform so that data generated in healthcare can be put to the greatest possible use. For healthcare, research and innovation. “This is...
Mutation in lung cancer patients linked to increased risk of brain metastases
A population-based study of 6,000 lung cancer patients shows that patients with the KRAS G12C mutation have a high risk of brain metastases. Surprisingly this is not linked to worse survival. The study was conducted by researchers affiliated with Genomic Medicine...
Using whole-genome sequencing in the diagnostics of acute lymphoblastic leukemia in children
A new Swedish study shows that whole genome sequencing can detect clinically relevant genomic abnormalities in acute lymphoblastic leukemia, ALL, and has great potential to be implemented in the diagnostic setting. The study, conducted by researchers within the GMS...